Elicio Therapeutics

1 stories about Elicio Therapeutics
הדמיה חיסון תרופה קורונה covid 19

Elicio Therapeutics enters Covid-19 vaccine race, reports success in pre-clinical trials

19.08.20|Sophie Shulman
Boston company partially owned by Clal Biotechnology Industries plans to advance to clinical trials in Q4